相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Dose escalation by intensity modulated radiotherapy in liver-directed concurrent chemoradiotherapy for locally advanced BCLC stage C hepatocellular carcinoma
Hwa Kyung Byun et al.
RADIOTHERAPY AND ONCOLOGY (2019)
Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion A Randomized Clinical Trial
MinKe He et al.
JAMA ONCOLOGY (2019)
Changes in real-life practice for hepatocellular carcinoma patients in the Republic of Korea over a 12-year period: A nationwide random sample study
Beom Kyung Kim et al.
PLOS ONE (2019)
KASL clinical practice guidelines for management of chronic hepatitis B
Hyung Joon Yim et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2019)
Unmet need in chronic hepatitis B management
Lilian Yan Liang et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2019)
Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update
Tae-Hyung Kim et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2019)
Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers
Yeun-Yoon Kim et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2019)
Bi-monthly hepatic arterial infusion chemotherapy as a novel strategy for advanced hepatocellular carcinoma in decompensated cirrhotic patients
Kei Moriya et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2019)
Appropriate treatment modality for solitary small hepatocellular carcinoma: Radiofrequency ablation vs. resection vs. transplantation?
Keun Soo Ahn et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2019)
Safety margin of embolized area can reduce local recurrence of hepatocellular carcinoma after superselective transarterial chemoembolization
Kittipitch Bannangkoon et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2019)
Ultraselective conventional transarterial chemoembolization: When and how?
Shiro Miyayama
CLINICAL AND MOLECULAR HEPATOLOGY (2019)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis
Jong Hwan Choi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)
Alastair D. Burt et al.
HISTOPATHOLOGY (2018)
Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma
Ning Lyu et al.
JOURNAL OF HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Efficacy and Safety of Transarterial Chemoembolization Plus External Beam Radiotherapy vs Sorafenib in Hepatocellular Carcinoma With Macroscopic Vascular Invasion A Randomized Clinical Trial
Sang Min Yoon et al.
JAMA ONCOLOGY (2018)
Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage A Phase 2 Clinical Trial
Mary Feng et al.
JAMA ONCOLOGY (2018)
Downstaging with Localized Concurrent Chemoradiotherapy Can Identify Optimal Surgical Candidates in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
Jae Uk Chong et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Hepatocellular Carcinoma with Portal Vein Tumor Involvement: Best Management Strategies
Po-Hong Liu et al.
SEMINARS IN LIVER DISEASE (2018)
Epidemiology of liver cancer in South Korea
Bo Hyun Kim et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2018)
Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion
Danbi Lee et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2018)
Transarterial Radioembolization Versus Concurrent Chemoradiation Therapy for Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
Jeong Eun Song et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies
Jordi Bruix et al.
JOURNAL OF HEPATOLOGY (2017)
Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis
Gonzalo Sapisochin et al.
JOURNAL OF HEPATOLOGY (2017)
Hepatocellular Carcinoma with Macrovascular Invasion: Defining the Optimal Treatment Strategy
Charlotte E. Costentin et al.
LIVER CANCER (2017)
VESPRO: An Individual Patient Data Prospective Meta-Analysis of Selective Internal Radiation Therapy Versus Sorafenib for Advanced, Locally Advanced, or Recurrent Hepatocellular Carcinoma of the SARAH and SIRveNIB Trials
Val Gebski et al.
JMIR RESEARCH PROTOCOLS (2017)
Real-Life Experience of Sorafenib Treatment for Hepatocellular Carcinoma in Korea: From GIDEON Data
Do Young Kim et al.
CANCER RESEARCH AND TREATMENT (2016)
Application of radiotherapy for hepatocellular carcinoma in current clinical practice guidelines
Chai Hong Rim et al.
RADIATION ONCOLOGY JOURNAL (2016)
A randomized study of cisplatin and 5-FU hepatic arterial infusion chemotherapy with or without adriamycin for advanced hepatocellular carcinoma
Myeong Jun Song et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Infiltrative Hepatocellular Carcinoma: What Radiologists Need to Know
Arich R. Reynolds et al.
RADIOGRAPHICS (2015)
Surgical Resection After Down-Staging of Locally Advanced Hepatocellular Carcinoma by Localized Concurrent Chemoradiotherapy
Hyung Soon Lee et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Combination treatment of localized concurrent chemoradiation therapy and transarterial chemoembolization in locally advanced hepatocellular carcinoma with intrahepatic metastasis
Mi Sung Park et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Infiltrating Hepatocellular Carcinoma: Seeing the Tree through the Forest
Aram Demirjian et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2011)
Radiosensitizers in Hepatocellular Carcinoma
Ik Jae Lee et al.
SEMINARS IN RADIATION ONCOLOGY (2011)
Positioning and Indication of Sorafenib in the Treatment Algorithm and Real Practice Setting: Western and Eastern Approach - Asian Perspective
Jung Min Lee et al.
ONCOLOGY (2010)
Compensatory enlargement of the liver after treatment of hepatocellular carcinoma with carbon ion radiotherapy - Relation to prognosis and liver function
Hiroshi Imada et al.
RADIOTHERAPY AND ONCOLOGY (2010)
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
Riccardo Lencioni et al.
SEMINARS IN LIVER DISEASE (2010)
Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis
J. H. Kim et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
The Clavien-Dindo Classification of Surgical Complications Five-Year Experience
Pierre A. Clavien et al.
ANNALS OF SURGERY (2009)
Accelerated Treatment Using Intensity-Modulated Radiation Therapy Plus Concurrent Capecitabine for Unresectable Hepatocellular Carcinoma
Alyson McIntosh et al.
CANCER (2009)
SIMULTANEOUS MULTITARGET IRRADIATION USING HELICAL TOMOTHERAPY FOR ADVANCED HEPATOCELLULAR CARCINOMA WITH MULTIPLE EXTRAHEPATIC METASTASES
Jeong Won Jang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Practical efficacy of sorafenib monotherapy for advanced hepatocellular carcinoma patients in a Hepatitis B virus-endemic area
Ju Hyun Shim et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis
Kwang-Hyub Han et al.
CANCER (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: A pilot study
Toru Ishikawa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma
Jun Yong Park et al.
CANCER (2007)
Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies
E Ben-Josef et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Evaluation of the lent-soma scales for the prospective assessment of treatment morbidity in cervical carcinoma
JA Routledge et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
分享论文
